BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30710804)

  • 21. Molecular Docking and Binding Mode Analysis of Plant Alkaloids as in vitro and in silico Inhibitors of Trypanothione Reductase from Trypanosoma cruzi.
    Argüelles AJ; Cordell GA; Maruenda H
    Nat Prod Commun; 2016 Jan; 11(1):57-62. PubMed ID: 26996020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotherapy of chagas' disease: an overview.
    Paulino M; Iribarne F; Dubin M; Aguilera-Morales S; Tapia O; Stoppani AO
    Mini Rev Med Chem; 2005 May; 5(5):499-519. PubMed ID: 15892691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
    Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
    Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved inhibitors of trypanothione reductase by combination of motifs: synthesis, inhibitory potency, binding mode, and antiprotozoal activities.
    Eberle C; Lauber BS; Fankhauser D; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2011 Feb; 6(2):292-301. PubMed ID: 21275053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 5,5'-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase: a microtiter colorimetric assay for inhibitor screening.
    Davioud-Charvet E; Becker K; Landry V; Gromer S; Logé C; Sergheraert C
    Anal Biochem; 1999 Mar; 268(1):1-8. PubMed ID: 10036154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of Trypanothione Reductase Inhibitors on
    Mendonça AAS; Coelho CM; Veloso MP; Caldas IS; Gonçalves RV; Teixeira AL; de Miranda AS; Novaes RD
    Oxid Med Cell Longev; 2018; 2018():8676578. PubMed ID: 30473742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach.
    Beig M; Oellien F; Garoff L; Noack S; Krauth-Siegel RL; Selzer PM
    PLoS Negl Trop Dis; 2015; 9(6):e0003773. PubMed ID: 26042772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics simulations of peptide inhibitors complexed with Trypanosoma cruzi trypanothione reductase.
    Silva Da Rocha Pita S; Batista PR; Albuquerque MG; Pascutti PG
    Chem Biol Drug Des; 2012 Oct; 80(4):561-71. PubMed ID: 22702225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease.
    Lo Presti MS; Bazán PC; Strauss M; Báez AL; Rivarola HW; Paglini-Oliva PA
    Acta Trop; 2015 May; 145():79-87. PubMed ID: 25733492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignment.
    da Rocha Pita SS; Albuquerque MG; Rodrigues CR; Castro HC; Hopfinger AJ
    Chem Biol Drug Des; 2012 May; 79(5):740-8. PubMed ID: 22269140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting effects of spermidine derivatives on Trypanosoma cruzi trypanothione reductase.
    O'Sullivan MC; Dalrymple DM; Zhou Q
    J Enzyme Inhib; 1996 Oct; 11(2):97-114. PubMed ID: 9204399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase.
    Blumenstiel K; Schöneck R; Yardley V; Croft SL; Krauth-Siegel RL
    Biochem Pharmacol; 1999 Dec; 58(11):1791-9. PubMed ID: 10571254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arylfurans as potential trypanosoma cruzi trypanothione reductase inhibitors.
    de Oliveira RB; Vaz AB; Alves RO; Liarte DB; Donnici CL; Romanha AJ; Zani CL
    Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):169-73. PubMed ID: 16830710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.